<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3089">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01797601</url>
  </required_header>
  <id_info>
    <org_study_id>Eudra-CT: 2006-002244-29</org_study_id>
    <secondary_id>17/2008AMG1</secondary_id>
    <nct_id>NCT01797601</nct_id>
  </id_info>
  <brief_title>Insulin Sensitivity of the Human CNS System: fMRI Study With Intranasal Insulin Application</brief_title>
  <official_title>Insulinsensitivit√§t Des Menschlichen Zentralnervensystems: Kernspintomographische Untersuchung Mit Intranasaler Gabe Von Insulin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <authority>Germany: Federal Institute for Drugs and Medical Devices</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to investigate whether insulin sensitivity and insulin
      resistance of the human brain is comparable in all insulin sensitive parts of the brain and
      whether correlates to other phenotypic information (i.e. whole body insulin sensitivity,
      BMI, age) of the study participants.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Insulin effect on regional brain activity assessed by fMRI</measure>
    <time_frame>Change from Baseline to 15 minutes and 60 minutes post spray application</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Obesity</condition>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Human Insulin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nasal spray</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo solution</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Nasal spray</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Human Insulin</intervention_name>
    <description>160 U of insulin</description>
    <arm_group_label>Human Insulin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Normal routine blood works

          -  for women: negative pregnancy test

          -  healthy

        Exclusion Criteria:

          -  Type 2 diabetes

          -  pregnancy

          -  acute or chronic diseases

          -  Pacemakers

          -  Artificial heart valves

          -  Metal prostheses

          -  Implanted magnetic metal parts (screws, ...)

          -  Metal fragments

          -  Braces

          -  insulin pumps

          -  Tattoos

          -  claustrophobia

          -  reduced temperature sensation and / or increased sensitivity to warming of the body

          -  Ear disease or an increased sensitivity to loud noises
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Fritsche, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Tuebingen, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Tuebingen</name>
      <address>
        <city>Tuebingen</city>
        <zip>72074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 6, 2014</lastchanged_date>
  <firstreceived_date>February 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Tuebingen</investigator_affiliation>
    <investigator_full_name>andreas fritsche</investigator_full_name>
    <investigator_title>Prof. Andreas Fritsche</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
